![](/img/cover-not-exists.png)
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer
Dorta-Estremera, Stephanie, Hegde, Venkatesh L., Slay, Ravaen B., Sun, Rachel, Yanamandra, Ananta V., Nicholas, Courtney, Nookala, Sita, Sierra, Gloria, Curran, Michael A., Sastry, K. JagannadhaVolume:
7
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/s40425-019-0728-4
Date:
December, 2019
File:
PDF, 1.61 MB
english, 2019